Poly Share Price Today: Live Chart, Targets & Buy/Sell Verdict

Investors tracking the legacy Poly stock often encounter a confusing market landscape following the company's high-profile acquisition. Because the original communications hardware firm no longer trades independently, understanding its current market value requires analyzing its parent company, HP Inc. This article breaks down the financial mechanics of that buyout, evaluates HP's current market performance, and examines Wall Street's latest price targets. It also clarifies common ticker confusion for global traders looking into unrelated domestic equities with similar names.

Why Poly's Stock Is No Longer Trading (HP Acquisition)

Poly's stock (formerly NYSE: POLY) is no longer trading because the company was fully acquired by HP Inc. and delisted from the New York Stock Exchange in August 2022. Investors searching for the active poly share price today will not find a live chart for the California-based communications firm, as it now operates entirely as a privately held subsidiary of HP.

A Look Back at HP's $3.3 Billion Buyout

HP acquired Poly (formerly Plantronics) to capture the surging demand for hybrid work peripherals, integrating Poly’s enterprise headsets and video conferencing hardware into HP’s commercial PC portfolio. Announced on March 28, 2022, and finalized on August 29, 2022, the buyout was structured as an all-cash transaction to rapidly scale HP's presence in a market requiring modernized home-office setups.

The strategic rationale relied heavily on scale efficiencies and cross-selling. HP projected the integration would generate $500 million in revenue synergies and improve Poly's operating margins by roughly six percentage points by fiscal year 2025.

What Happened to Poly's Existing Shareholders?

Upon the deal's closing, existing Poly shareholders received an automatic cash distribution of $40 per share directly into their brokerage accounts, and their equity positions were liquidated. Because this was an all-cash acquisition rather than a stock-for-stock merger, POLY investors did not receive HP Inc. (NYSE: HPQ) shares in exchange for their holdings.

The buyout executed through the following financial mechanics:

• Shareholder Approval: On June 23, 2022, over 80% of outstanding Poly common stock voted in favor of the definitive merger agreement, clearing the path for the buyout.
• The 53% Premium Realization: The $40 cash payout locked in a 53% premium over Poly’s final undisturbed closing price of $26.20 on March 25, 2022, giving shareholders immediate upside in exchange for future equity participation.
• Delisting: The POLY ticker was formally retired from the NYSE at the end of trading on August 29, 2022.
• Unvested Equity: Unvested restricted stock units (RSUs) held by Poly employees were converted into corresponding HP equity awards, preserving their original vesting schedules under the new parent company to retain talent.

Market Disambiguation Note: Because the legacy Plantronics/Poly entity no longer trades, users searching for active "poly" equities are typically looking for unrelated, publicly traded Indian manufacturing and medical firms. If you are researching active charts, your target is likely the poly medicure share price (NSE: POLYMED), the jindal poly film share price (NSE: JINDALPOLY), or the astral poly share price (NSE: ASTRAL)—none of which share a corporate relationship with the HP subsidiary.

What's Driving HP's (Poly's Parent Company) Price Today?

HP Inc. (NYSE: HPQ) shares are surging over 14% today, trading near $24.98 after breaking out from their previous $21.90 close. This aggressive upside is not driven by a single fundamental catalyst, but rather a combination of heavy pre-earnings positioning, fresh analyst price target hikes, and a newly declared quarterly dividend.

Are There Any Recent News or Announcements Moving HP's Stock?

Four distinct developments are fueling HP's current price action as markets front-run the company's upcoming financial disclosures.

• Fiscal Q2 2026 Earnings Anticipation: HP reports earnings on May 27, 2026. Options markets have priced in a larger-than-normal one-day swing, triggering heavy short-covering and speculative "catch-up" buying ahead of the release.
• Quarterly Dividend Declaration: On May 19, HP declared a $0.30 per share cash dividend payable on July 1, 2026. This reinforced institutional confidence in the company’s near-term free cash flow stability and management's commitment to returning capital.
• Analyst Target Revisions: Several firms adjusted targets upward this week. JPMorgan raised its price target to $22 (maintaining Neutral), while Morgan Stanley bumped its target to $17 (maintaining Underweight). Though not outright upgrades, the upward revisions improved near-term trading sentiment.
• AI PC & Windows 11 Tailwinds: Macro hardware data is supporting the PC manufacturer. IDC recently reported a 3% year-over-year jump in global PC shipments. With roughly 40% of the enterprise installed base still on Windows 10, markets are pricing in accelerated hardware refresh cycles tied to upcoming AI-powered devices.

What Do HP's Key Technical Indicators Say Right Now?

HP’s technical profile shifted from neutral to a consensus "Strong Buy" across daily timeframes following today’s breakout.

The immediate trade-off for new buyers is risk-to-reward: while technical momentum is definitively positive, entering at a 69.99 RSI ahead of a binary earnings event limits the margin of safety if management's Q2 guidance underwhelms.

Is HP's Current Volume Signaling Anything Unusual?

Yes, HP is experiencing massive volume expansion, confirming institutional accumulation rather than low-liquidity retail volatility. Average daily trading volume for HPQ typically ranges between 15 million and 18 million shares. As of midday trading, volume has already eclipsed 31 million shares—roughly double the historical average.

This equity volume is accompanied by a spike in derivatives activity. Bullish option flow accelerated this morning, with over 15,400 call contracts trading at 1.6 times their expected volume. Implied volatility has also expanded by more than a full point. When equity volume doubles concurrently with elevated call-buying and rising implied volatility, it signals that large funds are actively hedging or positioning for an outsized post-earnings move on May 27.

What Price Targets Are Analysts Setting for HP?

Wall Street analysts are currently projecting a muted to slightly negative outlook for HP Inc. (NYSE: HPQ), with the average price target sitting below the stock's mid-2026 trading range. Investors tracking the former poly share price must now evaluate HP’s consensus estimates, as the workplace peripherals manufacturer was fully absorbed into HP’s broader Personal Systems segment. Today, severe margin pressures and structural headwinds in the printing division outweigh the institutional optimism surrounding the AI-powered hardware refresh cycle.

What's HP's Consensus Target, and How Far Is It From Today's Price?

The median analyst price target for HP stands at $20.00, implying a roughly 8% downside from its late-May 2026 trading price of $21.90. The stock currently trades at a premium to the street's consensus expectations, driven higher by options market positioning ahead of earnings and a 5.7% forward dividend yield that provides a valuation floor.

Key consensus metrics for HPQ:

• Current Trading Price: ~$21.90 (as of May 2026)
• Median Price Target: $20.00
• Street-High Target: $26.40
• Street-Low Target: $16.00
• Consensus Rating: Hold (spanning 4 Buy, 8 Hold, and 5 Sell ratings across major coverage)

This negative implied upside is highly unusual for a major tech hardware firm in 2026. Institutional analysts largely view the recent stock price run-up as a speculative rotation rather than a reflection of fundamental earnings growth.

Which Analysts Are Most Bullish or Bearish, and Why?

Wall Street is sharply divided between bears modeling severe margin compression from rising component costs and moderate bulls forecasting a revenue bump from the Windows 11 commercial refresh.

Bears currently control the narrative. Firms like Goldman Sachs and Barclays cite a brutal memory cycle—rising costs for DRAM and NAND components—which directly compresses gross margins on HP's consumer hardware. Because HP lacks the pricing power to fully pass these costs onto retail consumers, analysts expect operating lines to degrade through the second half of 2026. The secular decline in the high-margin printing supplies business compounds this earnings drag.

The more optimistic outlooks, such as JPMorgan’s $22 target, rely heavily on commercial enterprise spending. These analysts point to the 40% of the installed corporate base still running Windows 10, expecting a mandatory hardware refresh cycle to drive unit volume through late 2026. They factor in the margin stability of the enterprise peripherals portfolio, which insulates the commercial solutions segment better than the consumer PC division. However, even the highest targets top out near $26, reflecting a rigid consensus that HP operates as a cash-generating value stock rather than a growth asset.

Should You Buy, Hold, or Sell HP Right Now?

Because of the global naming overlaps established earlier, investors tracking the poly share price today must evaluate its acquirer, HP Inc. (NYSE: HPQ). Those looking for unrelated Indian domestic equities—such as the poly medicure share price or jindal poly film share price—must refer to their specific NSE/BSE listings.

For HP Inc. (HPQ), the consensus verdict is a strong "Hold" for growth seekers and a cautious "Buy" for income-focused value investors. Trading near $21.90 as of late May 2026, the stock is deeply discounted at a trailing P/E ratio of 7.9x. It offers a robust 5.7% dividend yield, but faces persistent top-line revenue headwinds in its legacy print and PC divisions.

What Does the Technical Setup Suggest for Short-Term Traders?

Revisiting the short-term momentum metrics reveals the stock is approaching overbought territory. Traders positioning around quarterly earnings should monitor four distinct data points:

• Price vs. Moving Averages: HPQ trades at ~$21.90, comfortably above both its 50-day moving average ($21.06) and 200-day moving average ($20.60). This structural alignment confirms near-term upward momentum.
• Relative Strength Index (RSI): The 14-day RSI sits at 69.9, hovering immediately below the standard 70.0 threshold that categorizes an asset as technically overbought. Quantitative traders often use this boundary to tighten stop-losses.
• MACD Oscillator: The Moving Average Convergence Divergence (MACD) rests at 0.15. This positive divergence supports the recent price bounce heading into late-May earnings reports.
• Support and Resistance: Immediate resistance is capped at the recent local high of $22.60. If breached, the next psychological ceiling is $25.00. Downside support remains firmly established at the 50-day moving average of $21.06.

What Should Long-Term Investors Watch Before Deciding?

Long-term investors must weigh HP's exceptionally low valuation and high capital return against the structural stagnation of the broader consumer hardware market. The core tension for HPQ is distinguishing a genuine value play from a low-multiple value trap.

At a 7.9x price-to-earnings multiple, downside risk is heavily priced in, providing a margin of safety largely absent in mega-cap technology equities. The 5.7% dividend yield acts as a reliable shock absorber while investors wait for macroeconomic IT budgets to expand.

However, upside expansion depends entirely on enterprise spending behavior. HP relies on a dual-engine recovery: deploying Poly’s unified communications hardware to outfit hybrid office environments, and pushing AI-integrated PCs to force a corporate hardware upgrade cycle. If these product catalysts fail to accelerate revenue, HPQ will likely remain range-bound between $17 and $25, functioning strictly as an income-generating bond proxy rather than a growth asset.

FAQs about poly share price

Why is poly medicure falling?

Poly Medicure's stock has faced significant declines recently due to a combination of broader market headwinds and underwhelming company performance. In early 2026, the company reported that its quarterly earnings and revenues missed analyst expectations, with profit margins dropping to 14% largely due to higher expenses. Additionally, macroeconomic pressures like foreign institutional outflows and high valuation contractions have weighed heavily on Indian mid-cap stocks.

What is the analyst price target for Poly Medicure?

Analyst price targets for Poly Medicure vary depending on the brokerage and valuation model being used. As of mid-2026, the average 12-month price target generally ranges between ₹1,489 and ₹2,004. Some analysts have recently downgraded their fair value estimates due to updated assumptions regarding the company's profit margins, revenue growth, and future P/E multiples.

Is poly medicure a good buy for long term?

Poly Medicure possesses strong long-term fundamentals as a leading medical device manufacturer with extensive global exposure and a robust product portfolio. However, analysts remain cautious about near-term profit margins and the stock's relatively high valuation. Its long-term investment viability will largely depend on how well the company manages current cost pressures and whether it can capitalize on new strategic acquisitions and international trade agreements.

Is Poly Medicure stock considered overvalued at current levels?

Despite undergoing a steep price correction over the past year, Poly Medicure is still widely considered overvalued by multiple financial analysts. The stock currently trades at a high price-to-earnings (P/E) ratio of roughly 42 to 46x. Many valuation models suggest the company is trading at a significant premium to its intrinsic value, making it expensive relative to its current earnings.

Conclusion

Evaluating the historical Poly stock requires shifting focus to HP Inc., where the acquired communications portfolio now faces the broader realities of the consumer hardware market. While HP offers a compelling dividend yield and deep value metrics, its upside relies heavily on an anticipated enterprise upgrade cycle driven by AI-enabled PCs and integrated workplace peripherals. Investors must weigh these stable income streams against ongoing margin pressures and secular declines in legacy divisions. For those actually seeking active Indian equities like Poly Medicure, careful attention to local market fundamentals and valuation premiums remains essential.